Every day more and more investors head to the market in order to find stocks that may have gained strong momentum. More often than not such stocks can often help in delivering significant short term gain, driving interest towards these stocks that are gaining energy. Over the course of the past week, there were plenty of stocks that had gained momentum. This article is going to give you a quick look into some of those companies.

Gaensel Energy Group Inc (OTC:GEGR) - If you are currently on the lookout for holding companies with diversified interests then it may be a good time to start tracking Gaensel Energy Group Inc.

The company has been working on acquisitions and agreements since 2019 and is now involved in a range of industries starting from commodities and biotech to green energy and construction among others. It should be noted that Gaensel Energy Group has grown at a remarkable rate in the last two years. In 2019, the total assets under its control were valued at zero dollars but at the end of 2021, the total assets stood at $55 million.

The company has been working on acquisitions and agreements since 2019 and is now involved in a range of industries starting from commodities and biotech to green energy and construction among others. It should be noted that Gaensel Energy Group has grown at a remarkable rate in the last two years. In 2019, the total assets under its control were valued at zero dollars but at the end of 2021, the total assets stood at $55 million.

The company has been working on acquisitions and agreements since 2019 and is now involved in a range of industries starting from commodities and biotech to green energy and construction among others. It should be noted that Gaensel Energy Group has grown at a remarkable rate in the last two years. In 2019, the total assets under its control were valued at zero dollars but at the end of 2021, the total assets stood at $55 million.

The company is mainly involved in the automotive and electrical distribution industries. In light of the latest announcement, the stock experienced a degree of strong momentum, look for this stock to catch the attention of investors in the coming week.

Cann American (OTC: CNNA) - Another stock that managed to have strong momentum recently was the Cann American stock, which ended up with gains of as much as 115% this past Friday. The company had been established back in 2015 for the purpose of developing infrastructure projects for the cannabis industry in Northern California.

The company also owns a range of intellectual properties and back on November 8 this year it announced that it had signed another binding letter of intent. As per the agreement, Cann is going to pick up 75 million shares in Valkyrie Systems which is going to work out to a 75% stake. In exchange, the company would provide 10000000 series C preferred shares in Cann.

Sysorex Inc (OTC: SYSX) - Data center owner and operator Sysorex Inc was in considerable focus back on Friday and saw its stock deliver gains of as much as 80% amidst heavy interest.

The company is also known for its fully owned subsidiary unit Sysorex Government Services Inc which provides information technology solutions and products to federal organizations. The company was in the news back on November 30 after it announced that from November 25, 2022, its stock had been quoted on the OTC Pink Current Information tier. The news may have come as a source of optimism.

SmartMetric Inc (OTC: SMME) - Development stage technology company SmartMetric Inc saw its stock gain a certain degree of momentum recently. The company is involved in providing fingerprint sensor-activated security and payment cards. It is trying to make headway into the biometric card industry.

On Friday the company announced that it was in the final stages of manufacturing its biometric fingerprint credit card product.

Northwest Biotherapeutics (OTC:NWBO) - Last but not least it is Northwest Biotherapeutics that may be worth tracking at this point in time. The company is currently involved in the development of personalized immunotherapy products that are meant for treating different forms of cancers more effectively.

Last month the company provided positive top-line results from the Phase 3 trial of its product DCVax-L for Glioblastoma.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. CaptalGainsReport 'CGR' is responsible for the production and distributions of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has not been compensated to produce and syndicate this content. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website.

.

(C) 2022 M2 COMMUNICATIONS, source M2 PressWIRE